Value of a comprehensive exercise echocardiography assessment for patients with hypertrophic cardiomyopathy.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
05 2021
Historique:
received: 07 09 2020
revised: 09 11 2020
accepted: 23 11 2020
pubmed: 21 12 2020
medline: 25 11 2021
entrez: 20 12 2020
Statut: ppublish

Résumé

Exercise echocardiography (ExE) may assess left ventricular (LV) systolic and diastolic function, LV outflow tract (LVOT) obstruction, and mitral regurgitation (MR). We aimed to evaluate the prognostic value of these assessments during exercise in patients with hypertrophic cardiomyopathy (HCM). LV systolic function, LV-derived filling pressures, LVOT gradients, and MR were prospectively evaluated during treadmill ExE in 285 patients with HCM and preserved LV ejection fraction (EF) (≥50%). Recordings were obtained at rest and peak exercise for LV systolic function and at rest and post-exercise for LVOT gradients, MR, and ratio of early LV inflow velocity to early tissue Doppler annulus velocity (E/e´). Thirty-seven patients (13%) had LVOT obstruction at rest, and 76 (27%) developed exercise-induced LVOT obstruction. New wall motion abnormalities were detected in 38 patients (13%). E/e´>14 was observed in 129 patients at rest (45%) and in 134 at post-exercise (47%). Corresponding figures for significant MR (moderate or severe) were 21 (7%) and 17 (6%). During follow-up (3.9 ± 2.5 years), 27 patients had a hard event, 39 a combined event (hard plus new atrial fibrillation or syncope), and 58 a combined event or intervention. Exercise electrocardiographic testing, exercise LVEF, and the combination of positive ExE and increased E/e´ with exercise predicted outcome. The worst event rate corresponded to patients with raised E/e' values at post-exercise and positive ExE (annualized hard event-rate of 5.9%). A comprehensive assessment during ExE is feasible for patients with HCM and preserved LV systolic function, and provides significant incremental prognostic information.

Sections du résumé

BACKGROUND
Exercise echocardiography (ExE) may assess left ventricular (LV) systolic and diastolic function, LV outflow tract (LVOT) obstruction, and mitral regurgitation (MR). We aimed to evaluate the prognostic value of these assessments during exercise in patients with hypertrophic cardiomyopathy (HCM).
METHODS
LV systolic function, LV-derived filling pressures, LVOT gradients, and MR were prospectively evaluated during treadmill ExE in 285 patients with HCM and preserved LV ejection fraction (EF) (≥50%). Recordings were obtained at rest and peak exercise for LV systolic function and at rest and post-exercise for LVOT gradients, MR, and ratio of early LV inflow velocity to early tissue Doppler annulus velocity (E/e´).
RESULTS
Thirty-seven patients (13%) had LVOT obstruction at rest, and 76 (27%) developed exercise-induced LVOT obstruction. New wall motion abnormalities were detected in 38 patients (13%). E/e´>14 was observed in 129 patients at rest (45%) and in 134 at post-exercise (47%). Corresponding figures for significant MR (moderate or severe) were 21 (7%) and 17 (6%). During follow-up (3.9 ± 2.5 years), 27 patients had a hard event, 39 a combined event (hard plus new atrial fibrillation or syncope), and 58 a combined event or intervention. Exercise electrocardiographic testing, exercise LVEF, and the combination of positive ExE and increased E/e´ with exercise predicted outcome. The worst event rate corresponded to patients with raised E/e' values at post-exercise and positive ExE (annualized hard event-rate of 5.9%).
CONCLUSIONS
A comprehensive assessment during ExE is feasible for patients with HCM and preserved LV systolic function, and provides significant incremental prognostic information.

Identifiants

pubmed: 33341337
pii: S0914-5087(20)30396-8
doi: 10.1016/j.jjcc.2020.11.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

525-531

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing Interest There is no conflict of interest to disclose.

Auteurs

Jesus Peteiro (J)

Laboratory of Stress Echocardiography, Department of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, As Xubias, 84, 15006 A Coruña, Spain. Electronic address: pete@canalejo.org.

Roberto Barriales-Villa (R)

Service of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

José M Larrañaga-Moreira (JM)

Service of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

Alberto Bouzas-Mosquera (A)

Laboratory of Stress Echocardiography, Department of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, As Xubias, 84, 15006 A Coruña, Spain.

Cristina Martinez-Veira (C)

Service of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

Diana Castro-Dios (D)

Service of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

Xusto Fernández-Fernández (X)

Health in Code, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

Lorenzo Monserrat (L)

Health in Code, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, A Coruña, Spain.

Jose Vazquez-Rodriguez (J)

Laboratory of Stress Echocardiography, Department of Cardiology, Complejo Hospitalario Universitario de A Coruña (CHUAC), CIBER-CV, Universidad de A Coruña, As Xubias, 84, 15006 A Coruña, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH